| Dr Hamid Sharfuddin Hamdi, MD | |
|
17520 W Grand Pkwy S Ste 450, Sugar Land, TX 77479-4983 | |
| (713) 486-7800 | |
| (713) 486-7830 |
| Full Name | Dr Hamid Sharfuddin Hamdi |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 39 Years |
| Location | 17520 W Grand Pkwy S Ste 450, Sugar Land, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689645541 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | R1216 (Texas) | Secondary |
| 2084N0400X | Psychiatry & Neurology - Neurology | R1216 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Memorial Hermann Sugar Land Hospital | Sugar land, TX | Hospital |
| Memorial Hermann Hospital System | Houston, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ut Physicians | 2961732193 | 170 |
News Archive
Nuron Biotech Inc., a specialty biologics and vaccines company, today announced that it has secured an exclusive option and license agreement utilizing PolyTherics' site-specific TheraPEG PEGylation technology to develop NU400, a long-acting version of Nuron's proprietary recombinant human interferon beta-1b.
For patients with advanced, inoperable stage 3 lung cancer, concurrent chemotherapy and the specialized radiation treatment, proton therapy, offers improved survival compared to historical data for standard of care, according to a new study from The University of Texas MD Anderson Cancer Center.
"Twenty of the world's most troubled countries have made progress in efforts that range from reducing poverty to improving the education of girls and cutting down on the deaths of women in childbirth, the World Bank said on Wednesday" in a new report, Reuters reports.
Wake Forest University School of Medicine is one of 15 centers nationwide recruiting participants for a research study to evaluate the effectiveness of an investigational drug as an oral treatment for age associated memory impairment (AAMI), a condition that is marked by memory loss and poor concentration.
"The U.S. government has said it is hopeful that Zambia will be able to reduce maternal and child mortality, and has pledged to contribute" millions in funding to programs to help further that goal, the Times of Zambia reports.
› Verified 2 days ago
| Entity Name | Mhs Physicians Of Texas |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184714867 PECOS PAC ID: 1557254968 Enrollment ID: O20040207000177 |
News Archive
Nuron Biotech Inc., a specialty biologics and vaccines company, today announced that it has secured an exclusive option and license agreement utilizing PolyTherics' site-specific TheraPEG PEGylation technology to develop NU400, a long-acting version of Nuron's proprietary recombinant human interferon beta-1b.
For patients with advanced, inoperable stage 3 lung cancer, concurrent chemotherapy and the specialized radiation treatment, proton therapy, offers improved survival compared to historical data for standard of care, according to a new study from The University of Texas MD Anderson Cancer Center.
"Twenty of the world's most troubled countries have made progress in efforts that range from reducing poverty to improving the education of girls and cutting down on the deaths of women in childbirth, the World Bank said on Wednesday" in a new report, Reuters reports.
Wake Forest University School of Medicine is one of 15 centers nationwide recruiting participants for a research study to evaluate the effectiveness of an investigational drug as an oral treatment for age associated memory impairment (AAMI), a condition that is marked by memory loss and poor concentration.
"The U.S. government has said it is hopeful that Zambia will be able to reduce maternal and child mortality, and has pledged to contribute" millions in funding to programs to help further that goal, the Times of Zambia reports.
› Verified 2 days ago
| Entity Name | Ut Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265096317 PECOS PAC ID: 2961732193 Enrollment ID: O20191001001287 |
News Archive
Nuron Biotech Inc., a specialty biologics and vaccines company, today announced that it has secured an exclusive option and license agreement utilizing PolyTherics' site-specific TheraPEG PEGylation technology to develop NU400, a long-acting version of Nuron's proprietary recombinant human interferon beta-1b.
For patients with advanced, inoperable stage 3 lung cancer, concurrent chemotherapy and the specialized radiation treatment, proton therapy, offers improved survival compared to historical data for standard of care, according to a new study from The University of Texas MD Anderson Cancer Center.
"Twenty of the world's most troubled countries have made progress in efforts that range from reducing poverty to improving the education of girls and cutting down on the deaths of women in childbirth, the World Bank said on Wednesday" in a new report, Reuters reports.
Wake Forest University School of Medicine is one of 15 centers nationwide recruiting participants for a research study to evaluate the effectiveness of an investigational drug as an oral treatment for age associated memory impairment (AAMI), a condition that is marked by memory loss and poor concentration.
"The U.S. government has said it is hopeful that Zambia will be able to reduce maternal and child mortality, and has pledged to contribute" millions in funding to programs to help further that goal, the Times of Zambia reports.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Hamid Sharfuddin Hamdi, MD 6400 Fannin St Ste 2070, Houston, TX 77030-1541 Ph: (713) 486-8000 | Dr Hamid Sharfuddin Hamdi, MD 17520 W Grand Pkwy S Ste 450, Sugar Land, TX 77479-4983 Ph: (713) 486-7800 |
News Archive
Nuron Biotech Inc., a specialty biologics and vaccines company, today announced that it has secured an exclusive option and license agreement utilizing PolyTherics' site-specific TheraPEG PEGylation technology to develop NU400, a long-acting version of Nuron's proprietary recombinant human interferon beta-1b.
For patients with advanced, inoperable stage 3 lung cancer, concurrent chemotherapy and the specialized radiation treatment, proton therapy, offers improved survival compared to historical data for standard of care, according to a new study from The University of Texas MD Anderson Cancer Center.
"Twenty of the world's most troubled countries have made progress in efforts that range from reducing poverty to improving the education of girls and cutting down on the deaths of women in childbirth, the World Bank said on Wednesday" in a new report, Reuters reports.
Wake Forest University School of Medicine is one of 15 centers nationwide recruiting participants for a research study to evaluate the effectiveness of an investigational drug as an oral treatment for age associated memory impairment (AAMI), a condition that is marked by memory loss and poor concentration.
"The U.S. government has said it is hopeful that Zambia will be able to reduce maternal and child mortality, and has pledged to contribute" millions in funding to programs to help further that goal, the Times of Zambia reports.
› Verified 2 days ago
Raees Ahmed, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 2603 Sentry Oak Way, Sugar Land, TX 77479 Phone: 914-316-3031 | |
Aishwarya Raju, Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 3531 Town Center Blvd S Ste 102, Sugar Land, TX 77479 Phone: 713-429-5325 Fax: 281-816-5931 | |
Dr. Toby C Yaltho, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 16605 Southwest Fwy, Suite 600, Sugar Land, TX 77479 Phone: 281-494-6387 Fax: 281-494-6410 | |
Ateka Zaki, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 15200 Southwest Fwy, 240, Sugar Land, TX 77478 Phone: 281-242-5400 Fax: 281-242-5401 | |
Dr. Diana Maria Collins, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1 Sugar Creek Center Blvd, Suite 955, Sugar Land, TX 77478 Phone: 281-240-7477 Fax: 281-240-7508 | |
Kanwal Mirza, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 17510 W Grand Pkwy S Ste 460, Sugar Land, TX 77479 Phone: 281-766-4792 | |
Dr. Kimberly Kay Cress, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 77 Sugar Creek Center Blvd Ste 330, Sugar Land, TX 77478 Phone: 281-240-7000 Fax: 281-240-7017 |